The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7

被引:125
作者
Mongiat, M
Taylor, K
Otto, J
Aho, S
Uitto, J
Whitelock, JM
Iozzo, RV
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, JAH, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
[4] Commonwealth Sci & Ind Res Org Mol Sci, Sydney, NSW 2114, Australia
关键词
D O I
10.1074/jbc.275.10.7095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Perlecan is a multifaceted heparan sulfate proteoglycan that is expressed not only as an intrinsic constituent of basement membranes but also as a cell-surface and pericellular proteoglycan, Perlecan functions as a ligand reservoir for various growth factors that become stabilized against misfolding or proteolysis and acts as a co-receptor for basic fibroblast growth factor by augmenting high affinity binding and receptor activation. These biological properties are mediated by the heparan sulfate moiety, Rather little is known about the protein core's mediation of functions. We have recently discovered that fibroblast growth factor-7 (FGF7) binds to perlecan protein core and that exogenous perlecan efficiently reconstitutes FGF7 mitogenic activity in perlecan-deficient cells. In this report we examined the specific binding of FGF7 to various domains and subdomains of perlecan protein core. Using several experimental approaches including overlay protein assays, radioligand binding experiments, and the yeast two-hybrid system, me demonstrate that FGF7 binds specifically to the N-terminal half of domain III and to a lesser extent to domain V, with affinity constants in the range of 60 nM. Thus, perlecan protein core should be considered a novel biological ligand for FGF7, an interaction that could influence cancer growth and tissue remodeling.
引用
收藏
页码:7095 / 7100
页数:6
相关论文
共 36 条
[1]   KERATINOCYTE GROWTH-FACTOR - A FIBROBLAST GROWTH-FACTOR FAMILY MEMBER WITH UNUSUAL TARGET-CELL SPECIFICITY [J].
AARONSON, SA ;
BOTTARO, DP ;
MIKI, T ;
RON, D ;
FINCH, PW ;
FLEMING, TP ;
AHN, J ;
TAYLOR, WG ;
RUBIN, JS .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 638 :62-77
[2]   Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA [J].
Adatia, R ;
Albini, A ;
Carlone, S ;
Giunciuglio, D ;
Benelli, R ;
Santi, L ;
Noonan, DM .
ANNALS OF ONCOLOGY, 1997, 8 (12) :1257-1261
[3]   Two-hybrid analysis reveals multiple direct interactions for thrombospondin 1 [J].
Aho, S ;
Uitto, J .
MATRIX BIOLOGY, 1998, 17 (06) :401-412
[4]   Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA [J].
Aviezer, D ;
Iozzo, RV ;
Noonan, DM ;
Yayon, A .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :1938-1946
[5]   PERLECAN, BASAL LAMINA PROTEOGLYCAN, PROMOTES BASIC FIBROBLAST GROWTH FACTOR-RECEPTOR BINDING, MITOGENESIS, AND ANGIOGENESIS [J].
AVIEZER, D ;
HECHT, D ;
SAFRAN, M ;
EISINGER, M ;
DAVID, G ;
YAYON, A .
CELL, 1994, 79 (06) :1005-1013
[6]  
BATTAGLIA C, 1993, EUR J CELL BIOL, V61, P92
[7]   Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors [J].
BonnehBarkay, D ;
Shlissel, M ;
Berman, B ;
Shaoul, E ;
Admon, A ;
Vlodavsky, I ;
Carey, DJ ;
Asundi, VK ;
ReichSlotky, R ;
Ron, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (19) :12415-12421
[8]   The C-terminal domain V of perlecan promotes beta 1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans [J].
Brown, JC ;
Sasaki, T ;
Gohring, W ;
Yamada, Y ;
Timpl, R .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (01) :39-46
[9]   RECOMBINANT DOMAIN-III OF PERLECAN PROMOTES CELL ATTACHMENT THROUGH ITS RGDS SEQUENCE [J].
CHAKRAVARTI, S ;
HORCHAR, T ;
JEFFERSON, B ;
LAURIE, GW ;
HASSELL, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) :404-409
[10]  
COHEN IR, 1994, CANCER RES, V54, P5771